Guidance Point Advisors, LLC Johnson & Johnson Transaction History

Guidance Point Advisors, LLC

$331 Million
Q3 2024

A detailed history of Guidance Point Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Guidance Point Advisors, LLC holds 1,868 shares of JNJ stock, worth $290,417. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,868

Previous 1,854 0.76%

Holding current value

$290,417

Previous $270,000 11.85%

% of portfolio

0.09%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$145.48 - $167.38 $2,036 - $2,343	14 Added 0.76%	1,868 $302,000
Q2 2024 Jul 26, 2024	SELL	$144.38 - $157.78 $7,940 - $8,677	-55 Reduced 2.88%	1,854 $270,000
Q1 2024 May 10, 2024	BUY	$155.22 - $162.74 $10,244 - $10,740	66 Added 3.58%	1,909 $301,000
Q4 2023 Jan 30, 2024	BUY	$145.6 - $158.88 $10,628 - $11,598	73 Added 4.12%	1,843 $288,000
Q3 2023 Nov 06, 2023	SELL	$155.75 - $174.48 $4,516 - $5,059	-29 Reduced 1.61%	1,770 $275,000
Q2 2023 Jul 24, 2023	BUY	$154.35 - $166.11 $14,200 - $15,282	92 Added 5.39%	1,799 $297,000
Q1 2023 Apr 20, 2023	BUY	$151.05 - $180.26 $755 - $901	5 Added 0.29%	1,707 $264,000
Q4 2022 Jan 18, 2023	BUY	$160.2 - $179.79 $320 - $359	2 Added 0.12%	1,702 $0
Q3 2022 Oct 14, 2022	SELL	$161.33 - $179.52 $6,130 - $6,821	-38 Reduced 2.19%	1,700 $277,000
Q2 2022 Jul 28, 2022	SELL	$168.19 - $186.01 $5,382 - $5,952	-32 Reduced 1.81%	1,738 $308,000
Q1 2022 May 05, 2022	BUY	$158.14 - $179.59 $158 - $179	1 Added 0.06%	1,770 $313,000
Q4 2021 Jan 28, 2022	BUY	$155.93 - $173.01 $2,183 - $2,422	14 Added 0.8%	1,769 $302,000
Q3 2021 Oct 20, 2021	SELL	$161.5 - $179.47 $161 - $179	-1 Reduced 0.06%	1,755 $283,000
Q2 2021 Jul 20, 2021	BUY	$159.48 - $171.07 $1,594 - $1,710	10 Added 0.57%	1,756 $289,000
Q1 2021 Apr 30, 2021	BUY	$153.07 - $170.48 $5,357 - $5,966	35 Added 2.05%	1,746 $287,000
Q4 2020 Jan 15, 2021	BUY	$137.11 - $157.38 $274 - $314	2 Added 0.12%	1,711 $269,000
Q3 2020 Oct 16, 2020	BUY	$140.38 - $153.83 $3,790 - $4,153	27 Added 1.61%	1,709 $254,000
Q2 2020 Aug 03, 2020	SELL	$128.81 - $155.51 $28,724 - $34,678	-223 Reduced 11.71%	1,682 $236,000
Q1 2020 Apr 30, 2020	SELL	$111.14 - $153.99 $27,340 - $37,881	-246 Reduced 11.44%	1,905 $249,000
Q4 2019 Jan 15, 2020	BUY	$127.5 - $146.44 $255 - $292	2 Added 0.09%	2,151 $313,000
Q3 2019 Oct 08, 2019	BUY	$126.95 - $142.14 $51,033 - $57,140	402 Added 23.01%	2,149 $278,000
Q2 2019 Aug 05, 2019	BUY	$131.15 - $144.24 $262 - $288	2 Added 0.11%	1,747 $243,000
Q1 2019 May 06, 2019	BUY	$125.72 - $139.79 $125 - $139	1 Added 0.06%	1,745 $244,000
Q4 2018 Feb 13, 2019	BUY	$122.84 - $147.84 $214,232 - $257,832	1,744 New	1,744 $225,000

Others Institutions Holding JNJ

# of Institutions

4,227

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guidance Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guidance Point Advisors, LLC with notifications on news.

Account

Guidance Point Advisors, LLC Johnson & Johnson Transaction History